Martin Hessing, CEO, has a background in Biochemistry and Heamatology-Immunology (Utrecht University) and held postdoc positions at Kyushu University in Japan and Sanquin in Amsterdam. He obtained work and management experience at the TNO-Nutrition and Food Research Institute and Organon Teknika (now Biomerieux) industry. In 2000, he was co-founder of AM-Pharma BV, a biopharmaceutical company on anti-infectives and sepsis and lead compounds in Clinical Phase 2. In addition, Martin was involved as co-founder in Biorion BV and U-PACT BV and in a number of other biotech start-up companies in various positions. He is co-author of over 40 peer-reviewed papers and 6 patent applications. Martin is co-founder to U-Protein Express BV.